drugset / Trial / NCT01270841
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The Purpose of the study is to determine the effects of Androxal on morning testosterone and reproductive status in men with secondary hypogonadism(confirmed morning Testosterone less than 250 ng/dL), compared to changes with placebo, or Testim (topical testosterone). The effects of Testim versus placebo on reproductive status will also be examined. Study subjects must not be currently using a topical testosterone.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Androxal | Unknown | 12.5 mg | Oral |
| Subject | Androxal | Unknown | 25 mg | Oral |
| Comparator | Testosterone | Small molecule | — | Topical |